Gene: KMO
Official Full Name: kynurenine 3-monooxygenaseprovided by HGNC
Gene Summary: This gene encodes a mitochondrion outer membrane protein that catalyzes the hydroxylation of L-tryptophan metabolite, L-kynurenine, to form L-3-hydroxykynurenine. Studies in yeast identified this gene as a therapeutic target for Huntington disease. [provided by RefSeq, Oct 2011]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA12713 | KMO Knockout cell line (AC16) | Human | KMO | 1:3-1:4 | negative | Online Inquiry |
| KOA28155 | KMO Knockout cell line (BEAS-2B) | Human | KMO | 1:3~1:4 | negative | Online Inquiry |
| KOA43591 | KMO Knockout cell line (U-2932) | Human | KMO | 1:2-1:4 | negative | Online Inquiry |
| KOA58971 | KMO Knockout cell line (TPC-1) | Human | KMO | 1:5-1:8 | negative | Online Inquiry |
| KOA74394 | KMO Knockout cell line (NCM460) | Human | KMO | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.